Matia Mobility Secures HCPCS Code for Tek RMD: A Groundbreaking Solution Now Covered by Medicare, Commercial Insurance, and the VA

Matia Mobility, a leader in durable medical equipment, is proud to announce that the Centers for Medicare & Medicaid Services (CMS) has granted a HCPCS (Healthcare Common Procedure Coding System) code for the Tek RMD (Robotic Mobilization Device). This milestone makes standing mobility more accessible to individuals with walking disabilities confined to wheelchairs, providing new opportunities for independence and improving both physical and mental well-being.

The Tek RMD, now covered by Medicare, commercial insurance, and the U.S. Veterans Administration, is revolutionizing mobility by enabling users to stand and move at eye level, empowering them to participate fully in daily life. This includes tasks like cooking, reaching high shelves, and engaging in conversations and social interactions from a standing position, which promotes both confidence and social inclusion.

Benefits of Standing: More Than Just Mobility

The ability to stand has long been recognized for its numerous health benefits. Physically, standing helps improve circulation, reduce muscle atrophy, enhance bone density, and aid in digestive functions. These advantages are especially critical for individuals who spend extended periods in a seated position. Mentally, standing fosters a sense of empowerment and autonomy, reducing the emotional and psychological strain often associated with being wheelchair-bound. Standing upright allows users to see the world from a new perspective, positively impacting their self-esteem and social interactions.

Beyond the physical and mental health benefits, standing at eye level enables individuals to carry out activities of daily living (ADLs) more easily. Whether it’s preparing meals, doing household chores, going to work, or even pursuing hobbies and interests, the Tek RMD allows users to regain control over their lives in ways that were previously unimaginable. This is particularly impactful for veterans and others with service-related disabilities, who can now experience a new level of freedom and dignity.

Expanded Coverage and Accessibility

With the HCPCS code now approved, individuals across the country can access the Tek RMD with greater ease, and financial barriers are significantly reduced. The device’s inclusion in Medicare coverage is complemented by support from major commercial insurers, making this innovative solution even more accessible. The U.S. Veterans Administration’s coverage of the Tek RMD is another major step in honoring and supporting veterans, particularly those who have sustained mobility-limiting injuries during their service.

“We are incredibly excited about this development,” said Steven Boal, CEO of Matia Mobility. “Receiving the HCPCS code from CMS means more people will have access to the life-changing benefits of the Tek RMD. Whether through Medicare, private insurance, or VA benefits, our goal is to help as many individuals as possible reclaim their independence and improve their quality of life.”

Matia Mobility has made insurance prior authorization accessible via its website at https://www.matiamobility.com.

For more information about the Tek RMD and how to access coverage, visit https://www.matiamobility.com.

About Matia Mobility

Matia Mobility is committed to providing innovative mobility solutions that enhance independence, dignity, and quality of life for individuals with disabilities. With a focus on cutting-edge technology and personalized care, Matia Mobility helps people of all ages and abilities experience new possibilities in mobility and daily living. Matia Mobility, reimagining mobility for people with walking disabilities.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”